Research ArticleClinical Studies
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI and YOKO FURUKAWA-HIBI
Anticancer Research April 2026, 46 (4) 2187-2198; DOI: https://doi.org/10.21873/anticanres.18107
YOSUKE SUGIYAMA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
TAKU NAIKI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
3Department of Urology, Nagoya West Medical Center, Nagoya, Japan
TOSHIHARU MORIKAWA
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
KUNIHIRO ODAGIRI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
YOSHIHISA MIMURA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
YOSHIHIKO TASAKI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
NOBUHIKO SHIMIZU
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
TAKASHI NAGAI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
TOSHIKI ETANI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
DAIKI ISHIKAWA
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
MISATO TOMITA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
MOEKO IIDA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
NANAMI ITO
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
YUKA KIMURA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
YUJI HOTTA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
TAKAHIRO YASUI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
YOKO FURUKAWA-HIBI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Anticancer Research
Vol. 46, Issue 4
April 2026
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI, YOKO FURUKAWA-HIBI
Anticancer Research Apr 2026, 46 (4) 2187-2198; DOI: 10.21873/anticanres.18107
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI, YOKO FURUKAWA-HIBI
Anticancer Research Apr 2026, 46 (4) 2187-2198; DOI: 10.21873/anticanres.18107
Jump to section
Related Articles
Cited By...
- No citing articles found.





